Loading...

In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance

BACKGROUND: Raloxifene hydrochloride (RLX) is approved by the US Food and Drug Administration for the treatment and prevention of osteoporosis, in addition to reducing the risk of breast cancer in postmenopausal women. RLX has the disadvantages of low aqueous solubility, extensive presystemic intest...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Nanomedicine
Main Authors: Ahmed, Osama AA, Badr-Eldin, Shaimaa M
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6188068/
https://ncbi.nlm.nih.gov/pubmed/30349253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S181587
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!